|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Net sales | ||
| Cost of sales | ||
| Gross profit | ||
| Operating expenses: | ||
| Research and development | ||
| Sales and marketing | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expense): | ||
| Interest income | ||
| Other expense | ||
| Change in fair value of warrant liabilities | ||
| Total other expense, net | ||
| Net loss | ||
| Other comprehensive income (loss): | ||
| Unrealized gain (loss) on short-term and long-term investments | ||
| Comprehensive loss | ||
| Net loss per share attributable to common stockholders, basic | ||
| Net loss per share attributable to common stockholders, diluted | ||
| Weighted-average common shares outstanding, basic | ||
| Weighted-average common shares outstanding, diluted |
Loading...
